We chat with AboGen Co-Founder and CSO Stephen Andrews
Multi-omic data from NASA twin study has implications for life in space and on Earth
Sequencing rivals face off over the nature of nanopores
Laboratory will be the first with national-level specialisation in precision medicine applied to blood transfusion
Curoverse launch software on Microsoft platform following “clear demand” from customers.
In spite of the looming patent dispute of CRISPR, Editas Medicine look set to go public in 2016
Landmark US case attempts to set a new precedent for use of genetic information.
London’s Institute of Cancer Research has unveiled plans for a new global hub for cancer research and treatment
Study of infertility in human embryos using CRISPR gene-editing technique is given the go-ahead in the UK
US Patent Office declares ‘interference’ between patents from Doudna and Zhang
2016 to see the launch of new Wellcome Genome Campus innovation centre for genomics and biodata businesses.
Scientists from Duke University used gene-editing technique to treat Duchenne muscular dystrophy in grown animals. 2016 is barely a fortnight old, and already CRISPR-Cas9 has leapt into the headlines again. On New Year’s Eve three research groups reported in Science that they had successfully used CRISPR to treat Duchenne muscular dystrophy (DMD) in mice, marking the first time the […]
Illumina spin-off Grail aims to develop $1000 or less tests for early cancer diagnosis.
Have your say in our latest poll: full patient access to genomic data. A no-brainer, or a bad idea?
Over the last few months, Genomics England have been hosting a series of seminars in London, UK for the clinical and research communities involved with the 100,000 Genomes Project. Experts from around the world have been invited to explore a diverse range of topics relating to genomic medicine, and now those presentations are available online. […]